Perioperative nivolumab monotherapy versus nivolumab plus ipilimumab in resectable hepatocellular carcinoma: a randomised, open-label, phase 2 trialAhmed O. Kaseb, Padmanee Sharma, Aliya Qayyum et al.|The Lancet. Gastroenterology & hepatology|2022Cited by 255
A Visually Apparent and Quantifiable CT Imaging Feature Identifies Biophysical Subtypes of Pancreatic Ductal AdenocarcinomaEugene J. Koay, Jason B. Fleming, Yeon‐Ju Lee et al.|Clinical Cancer Research|2018Cited by 111
An Integrated Computational/Experimental Model of Lymphoma GrowthHermann B. Frieboes, Vittorio Cristini|PLoS Computational Biology|2013Cited by 35
Predictive Modeling of Drug Response in Non-Hodgkin’s LymphomaHermann B. Frieboes, Vittorio Cristini|PLoS ONE|2015Cited by 25